Rare disease therapeutics with Jack Borrok of Amgen

Texas Biologics
Event starts on this day

Nov

7

2024

Event starts at this time 9:30 am – 11:00 am
In Person (view details)
Featured Speaker(s): Jack Borrock
Cost: Free
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.

Description

Jack Borrok

Jack Borrok, Ph.D., is the senior director of Amgen and will discuss “Rare disease therapeutics.” Borrok is a postdoctoral alumnus of the Georgiou lab.

This is one talk in a series from Texas Biologics this fall covering cutting-edge technology developments across a range of research fields, from mRNA drug discovery to genetic engineering technologies for de-extinction to biologics design and engineering. Their speakers will include experts from Amgen and Regeneron.

Location

NHB 1.720

Share


Other Events in This Series

Nov

19

2024

Research Learning

Cell medicines with Mark Pogson of Regeneron

Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.

9:30 am – 11:00 am In Person

Speaker(s): Mark Pogson

Feb

13

2025

Research Learning

CMC in the Therapeutic Development Process with Olga Paley of Takeda

Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.

11:00 am – 12:00 pm In Person

Speaker(s): Olga Paley